Pablo UMAÑA

City:

Lachen

Country:

Switzerland

Published Applications:

Last publication date:

2026-07-02

Top Assignees for applications by Pablo UMAÑA

The entities that hold a legal rights for patent applications filed by inventor UMAÑA Pablo:

HOFFMANN-LA ROCHE INC. 10 Little Falls, NJ United States

Recent patent applications by UMAÑA Pablo

Pablo UMAÑA from Lachen, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-07-02

US20260184787A1

Chemistry; metallurgy

COMBINATION THERAPY WITH ANTI-CD19/ANTI-CD28 BISPECIFIC ANTIBODY

#2 | 2026-03-12

US20260070940A1

Chemistry; metallurgy

STABILIZED IMMUNOGLOBULIN DOMAINS

#3 | 2026-02-05

US20260035462A1

Chemistry; metallurgy

PROTEASE-ACTIVATABLE T CELL BISPECIFIC ANTIBODIES

#4 | 2025-10-30

US20250333542A1

Chemistry; metallurgy

INTERFERON GAMMA VARIANTS AND ANTIGEN BINDING MOLECULES COMPRISING THESE

#5 | 2025-06-05

US20250179205A1

Chemistry; metallurgy

NOVEL BISPECIFIC ANTIGEN BINDING MOLECULES CAPABLE OF SPECIFIC BINDING TO CD40 AND TO FAP

#6 | 2025-03-27

US20250101132A1

Chemistry; metallurgy

COMBINATION THERAPY OF ANTI-TYRP1/ANTI-CD3 BISPECIFIC ANTIBODIES AND TYRP1-SPECIFIC ANTIBODIES

#7 | 2025-03-20

US20250092128A1

Chemistry; metallurgy

FOLR1 PROTEASE-ACTIVATABLE T CELL BISPECIFIC ANTIBODIES

#8 | 2024-12-26

US20240425561A1

Chemistry; metallurgy

NEW INTERLEUKIN-7 IMMUNOCONJUGATES

#9 | 2024-11-14

US20240376205A1

Chemistry; metallurgy

TARGETED INTERFERON ALPHA FUSION PROTEINS AND METHODS OF USE

#10 | 2024-08-15

US20240269277A1

Human necessities

ALTERNATIVE PD1-IL7V IMMUNOCONJUGATES FOR THE TREATMENT OF CANCER

InventorID:

6747825 ⎘